RESEARCH-USE BIOSIMILAR ANTIBODY
Lacnotuzumab
Monoclonal antibody · IgG1
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis.
TARGETCSF1
YMonoclonal antibody
CATALOGSC-BS-454
CATALOG NUMBERSC-BS-454
MOLECULAR WEIGHTApprox. 144.8 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis.
Lacnotuzumab is a recombinant research-use antibody directed against CSF1.